Phase I and Pharmacokinetic Studies of Difluoromethylor - Patrick Creaven

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: Division of Cancer Prevention And Control (NCI)
Type: Research and Development Contracts (N01)
Project #: N01CN085102-002002
Application #: 3622063
Study Section

Project Start: 1990-06-29
Project End
Budget Start: 1993-08-04
Budget End: 1993-12-31
Support Year
Fiscal Year: 1993
Total Cost
Indirect Cost

Institution

Name: Roswell Park Cancer Institute Corp
Department
Type
DUNS #

City: Buffalo
State: NY
Country: United States
Zip Code: 14263

Related projects


NIH 1993 N01 CN	Phase I and Pharmacokinetic Studies of Difluoromethylor Creaven, Patrick J. / Roswell Park Cancer Institute Corp
NIH 1992 N01 CN	Phase I and Pharmacokinetic Studies of Difluoromethylor Creaven, Patrick J. / Roswell Park Cancer Institute Corp
NIH 1990 N01 CN	Phase I and Pharmacokinetic Studies of Difluoromethylor Creaven, Patrick J. / Roswell Park Cancer Institute Corp
NIH 1989 N01 CN	Phase I and Pharmacokinetic Studies of Difluoromethylor Creaven, Patrick J. / Roswell Park Cancer Institute Corp

Publications

Pendyala, L; Creaven, P J (1995) Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial. Cancer Epidemiol Biomarkers Prev 4:245-51

Pendyala, L; Creaven, P J; Porter, C W (1993) Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial. Cancer Epidemiol Biomarkers Prev 2:235-41

Comments

Be the first to comment on Patrick Creaven's grant